Physician profile
Alan Stuart Oster
NPI 1598792780
$18,016.24
in general payments reported to CMS, 2019-2025
35 companies · $5,485 in 2025
The $5,485 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $1,145 · 2021: $2,782 · 2022: $1,306 · 2023: $2,621 · 2024: $4,335 · 2025: $5,485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,244 · Food and Beverage: $4,968 · Education: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,244.12 |
| Food and Beverage | $4,968.49 |
| Education | $229.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $11,846.83 | 2020-2025 | Persona, Oxford, Rosa |
| Stryker Corporation | $1,468.28 | 2023-2025 | Mako, Triathlon, Inspace |
| Legacy Ortho LLC | $1,200.00 | 2021 | |
| Encore Medical, Lp | $853.49 | 2021 | |
| Depuy Synthes Sales INC. | $542.14 | 2020-2025 | Va-Lcp, Na, Tfn-Advance |
| Pacira Pharmaceuticals Incorporated | $353.11 | 2021-2025 | Exparel, Zilretta, Iovera |
| Pacira Therapeutics, INC. | $347.76 | 2019-2021 | |
| Smith+Nephew, INC. | $226.07 | 2019-2022 | |
| Si-Bone, INC. | $198.87 | 2021-2023 | |
| Ferring Pharmaceuticals INC. | $128.01 | 2019-2023 | Euflexxa |
| Medical Device Business Services, INC. | $100.15 | 2019-2023 | |
| Bone Support INC. | $82.07 | 2024-2025 | Ceramentbone Void Filler, Cerament G |
| Blue Surgical LLC | $80.10 | 2025 | |
| Bioventus LLC | $76.58 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Kowa Pharmaceuticals America, INC. | $55.16 | 2023 | Seglentis |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $52.05 | 2025 | Cmf |
| Sanara Medtech INC. | $49.59 | 2023 | Celleraterx |
| Kci USA, INC. | $34.13 | 2020 | |
| Acumed LLC | $29.69 | 2020-2023 | Acumed, Innate Implant |
| Dynasplint Systems INC. | $28.98 | 2022-2025 | Dynasplint |
| Pfizer INC. | $26.79 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $25.42 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $24.12 | 2025 | |
| Orthalign INC | $22.37 | 2024 | Orthalign Plus |
| Bsn Medical INC | $20.74 | 2022 | |
| Abbott Laboratories | $20.66 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.12 | 2024 | Lifevest |
| Organogenesis INC. | $16.75 | 2022 | |
| My01 INC. | $14.91 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Medartis INC. | $14.81 | 2020 | |
| Endo Pharmaceuticals INC. | $13.47 | 2020 | |
| Amgen INC. | $13.18 | 2024 | Evenity |
| Merck Sharp & Dohme LLC | $12.89 | 2023 | Verquvo |
| Fx Shoulder Solutions, INC | $11.33 | 2019 | |
| Aroa Biosurgery Incorporated | $5.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Oster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.